List Results
Refine Search
Results by Topic
Results on Map
Search Details
Found 2302 studies with search of: "Leukemia"
Hide studies that are not seeking new volunteers.
  Display Options
Rank Status Study
1 Active, not recruiting Phase 1 Study of Terameprocol (EM-1421) in Patients With Leukemia
Conditions: Leukemias;   Acute Myeloid Leukemia (AML);   Acute Lymphocytic Leukemia (ALL);   Adult T Cell Leukemia (ATL);   Chronic Myeloid Leukemia (CML-BP);   Chronic Lymphocytic Leukemia (CLL);   Myelodysplastic Syndrome (MDS);   Chronic Myelomonocytic Leukemia (CMML)
Intervention: Drug: Terameprocol (EM-1421)
2 Recruiting Phase I Dose-Escalation Trial of Clofarabine Followed by Escalating Doses of Fractionated Cyclophosphamide in Children With Relapsed or Refractory Acute Leukemias
Conditions: Myelodysplastic Syndrome;   Acute Myeloid Leukemia;   Myeloproliferative Disorders;   Acute Lymphocytic Leukemia;   Acute Promyelocytic Leukemia;   Acute Leukemia;   Chronic Myelogenous Leukemia;   Myelofibrosis;   Chronic Myelomonocytic Leukemia;   Juvenile Myelomonocytic Leukemia
Interventions: Drug: Clofarabine;   Drug: Cyclophosphamide
3 Recruiting A Safety and Dose-Finding Study of JNJ-26481585 for Patients With Advanced of Refractory Leukemia or Myelodysplastic Syndrome.
Conditions: Leukemia, Myelogenous, Chronic, BCR-ABL Positive;   Myelodysplastic Syndromes;   Leukemia, Lymphocytic, Chronic, B-Cell;   Leukemia, Myeloid, Acute;   Precursor Cell Lymphoblastic Leukemia-Lymphoma
Intervention: Drug: JNJ-26481585.
4 Recruiting Phase I Study of ON 01910.Na in Refractory Leukemia or Myelodysplastic Syndrome (MDS)
Conditions: Acute Myelocytic Leukemia;   Acute Lymphocytic Leukemia;   Chronic Myelocytic Leukemia;   Chronic Lymphocytic Leukemia;   Myelodysplastic Syndromes
Intervention: Drug: ON 01910.Na
5 Recruiting Molecular Epidemiology of Childhood Leukemia in Northern and Central California
Conditions: Leukemia;   Acute Myelocytic Leukemia;   Acute Lymphoblastic Leukemia;   Acute Myelogenous Leukemia
Intervention:
6 Recruiting Lenalidomide in Acute Leukemias and Chronic Lymphocytic Leukemia.
Conditions: Acute Myeloid Leukemia;   Acute Lymphoblastic Leukemia;   Chronic Lymphocytic Leukemia
Intervention: Drug: lenalidomide
7 Terminated An Ascending Dose Study of KW-2449 in Acute Leukemias, Myelodysplastic Syndromes, and Chronic Myelogenous Leukemia
Conditions: Acute Myelogenous Leukemia;   Acute Lymphoblastic Leukemia;   Myelodysplastic Syndromes;   Chronic Myelogenous Leukemia
Intervention: Drug: KW-2449
8 Recruiting Bendamustine in Acute Leukemia and MDS
Conditions: Acute Myeloid Leukemia;   Myelodysplastic Syndrome;   Acute Lymphoblastic Leukemia;   Chronic Myeloid Leukemia
Intervention: Drug: Bendamustine
9 Recruiting Haploidentical Transplantation in Patients With Acute Leukemia and Myelodysplasia
Conditions: Acute Myelogenous Leukemia;   Acute Lymphocytic Leukemia;   Myelodysplastic Syndrome;   Leukemia
Interventions: Drug: Fludarabine;   Drug: Thiotepa;   Radiation: Total Body Irradiation
10 Terminated Study of Farnesyl Protein Transferase Inhibitor (FPTI) in Patients With Leukemia (Study P00701)(TERMINATED)
Conditions: Leukemia;   Myelodysplastic Syndromes;   Leukemia, Myeloid, Chronic;   Blast Crisis;   Leukemia, Lymphocytic
Intervention: Drug: Farnesyl Protein Transferase Inhibitor
11 Withdrawn Donor Stem Cell Transplant in Treating Patients With Acute Myeloid Leukemia in Remission
Conditions: Adult Acute Erythroid Leukemia;   Adult Acute Monoblastic and Acute Monocytic Leukemia;   Adult Acute Myeloid Leukemia
Interventions: Drug: anti-thymocyte globulin;   Drug: fludarabine phosphate;   Drug: thiotepa;   Procedure: biological therapy;   Procedure: bone marrow ablation with stem cell support;   Procedure: chemotherapy;   Procedure: non-specific immune-modulator therapy;   Procedure: peripheral blood stem cell transplantation;   Procedure: radiation therapy
12 Recruiting Study of SNS-595 in Older Patients With Untreated Acute Myeloid Leukemia
Conditions: Leukemia;   Acute Disease;   Acute Myeloid Leukemia;   Nonlymphocytic Leukemia;   Myelodysplastic Syndromes
Intervention: Drug: SNS-595
13 Active, not recruiting An Extension Study of the Safety and Anti-Leukemic Effects of Imatinib Mesylate in Adult Patients With Ph + Leukemia
Condition: Philadelphia Positive Chronic Myeloid Leukemia in Accelerated Phase, Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia
Intervention: Drug: imatinib mesylate
14 Active, not recruiting An Extension Study of the Safety and Anti-Leukemic Effects of Imatinib Mesylate in Adult Patients With Ph + Leukemia
Condition: Philadelphia Positive Chronic Myeloid Leukemia in Accelerated Phase, Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia
Intervention: Drug: imatinib mesylate
15 Recruiting Single Versus Double Umbilical Cord Blood Transplantation in Children With High Risk Leukemia and Myelodysplasia
Conditions: Acute Myelogenous Leukemia;   Acute Lymphocytic Leukemia;   Chronic Myelogenous Leukemia;   Myelodysplastic Syndrome;   NK Cell Lymphoblastic Leukemia
Interventions: Biological: Single Cord Blood Unit Transplantation;   Biological: Double Cord Blood Unit Transplantation
16 Active, not recruiting Investigation of Clofarabine in Acute Leukemias
Conditions: Acute Myelogenous Leukemia;   Acute Lymphocytic Leukemia;   Chronic Myelogenous Leukemia
Intervention: Drug: clofarabine
17 Recruiting Homoharringtonine in Treating Patients With Chronic Myeloid Leukemia (CML) With the T315I BCR-ABL Gene Mutation
Conditions: Myeloid Leukemia, Chronic;   Myeloid Leukemia, Chronic, Accelerated-Phase;   Blast Phase;   Myeloid Leukemia, Chronic, Chronic-Phase
Intervention: Drug: Homoharringtonine
18 Not yet recruiting Pilot Study for Patients With Chemotherapy Resistant or Refractory CD19 Leukemia and Lymphoma
Conditions: Acute Lymphocytic Leukemia;   Follicular Lymphoma;   Chronic Lymphocytic Leukemia (CLL);   Mantle Cell Lymphoma;   Prolymphocytic Leukemia;   Large Cell Lymphoma
Intervention: Biological: CART-19
19 Completed MK0457 in Patients With Leukemia
Conditions: Chronic Myelogenous Leukemia in Blast Crisis;   Lymphocytic Leukemia, B Cell, Acute;   Myelodysplastic Syndromes;   Myelogenous Leukemia, Chronic
Intervention: Drug: MK0457
20 Completed Dasatinib (BMS-354825) in Subjects With Lymphoid Blast Phase Chronic Myeloid Leukemia or Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia
Conditions: Chronic Myeloid Leukemia;   Leukemia, Lymphoblastic, Acute, Philadelphia-Positive
Intervention: Drug: Dasatinib

Previous Page Studies Shown (1-20) Next Page (21-40)
Save this search by bookmarking this page.
When you use your bookmark, the search will be performed again on the most recent collection of studies.
  RSS Feed for studies found by your search that were received in the last 14 days
  Download Options




U.S. National Library of Medicine,  Contact Help Desk
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services